GHDX - Genomic Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52B
Enterprise Value 31.85B
Trailing P/E 48.63
Forward P/E 133.47
PEG Ratio (5 yr expected) 12.55
Price/Sales (ttm)4.87
Price/Book (mrq)6.94
Enterprise Value/Revenue 34.51
Enterprise Value/EBITDA 639.83

Trading Information

Stock Price History

Beta (3Y Monthly) 1.31
52-Week Change 38.14%
S&P500 52-Week Change 37.40%
52 Week High 392.18
52 Week Low 348.72
50-Day Moving Average 354.64
200-Day Moving Average 366.74

Share Statistics

Avg Vol (3 month) 3530.41k
Avg Vol (10 day) 3572.07k
Shares Outstanding 537.07M
Float 24.62M
% Held by Insiders 12.77%
% Held by Institutions 186.93%
Shares Short (Jun 14, 2019) 41.27M
Short Ratio (Jun 14, 2019) 42.77
Short % of Float (Jun 14, 2019) 44.74%
Short % of Shares Outstanding (Jun 14, 2019) 43.42%
Shares Short (prior month May 15, 2019) 42.3M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 10.35%
Operating Margin (ttm)9.10%

Management Effectiveness

Return on Assets (ttm)7.34%
Return on Equity (ttm)17.39%

Income Statement

Revenue (ttm)410.26M
Revenue Per Share (ttm)11.36
Quarterly Revenue Growth (yoy)17.40%
Gross Profit (ttm)269.19M
Net Income Avi to Common (ttm)42.45M
Diluted EPS (ttm)1.11
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)205.96M
Total Cash Per Share (mrq)5.56
Total Debt (mrq)58.38M
Total Debt/Equity (mrq)20.28
Current Ratio (mrq)5.67
Book Value Per Share (mrq)7.77

Cash Flow Statement

Operating Cash Flow (ttm)66.61M
Levered Free Cash Flow (ttm)39.86M